AAAAAA

   
Results: 1-21 |
Results: 21
Donor bone marrow cells used for the induction of allograft acceptance in clinical transplantation as regulators of autologous immune responses
Authors: Mathew, JM Fuller, L Carreno, M Burke, GW Ciancio, G Ricordi, C Tzakis, AG Esquenazi, V Miller, J
Citation: Jm. Mathew et al., Donor bone marrow cells used for the induction of allograft acceptance in clinical transplantation as regulators of autologous immune responses, TRANSPLAN P, 33(1-2), 2001, pp. 108-109
Cells of donor phenotype present in renal transplant recipients infused with donor marrow: Potent regulators of antidonor immune responses of the recipient
Authors: Mathew, JM Garcia-Morales, R Fuller, L Rosen, A Burke, GW Ciancio, G Carreno, M Ricordi, C Tzakis, AG Esquenazi, V Miller, J
Citation: Jm. Mathew et al., Cells of donor phenotype present in renal transplant recipients infused with donor marrow: Potent regulators of antidonor immune responses of the recipient, TRANSPLAN P, 33(1-2), 2001, pp. 127-128
Daclizumab induction for primary kidney transplant recipients using tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression
Authors: Ciancio, G Miller, A Burke, GW Gharagozloo, H Rosen, A Roth, D Kupin, W Pinna, A Cespedes, M Esquenazi, V Miller, J
Citation: G. Ciancio et al., Daclizumab induction for primary kidney transplant recipients using tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression, TRANSPLAN P, 33(1-2), 2001, pp. 1013-1014
Induction therapy with daclizumab as part of the immunosuppressive regimenin human small bowel and multiorgan transplants
Authors: Carreno, MR Kato, T Weppler, D Mathew, JM Fuller, L Gomez, C Salman, F Garcia-Morales, R Ciancio, G Burke, GW Esquenazi, V Miller, J Tzakis, AG
Citation: Mr. Carreno et al., Induction therapy with daclizumab as part of the immunosuppressive regimenin human small bowel and multiorgan transplants, TRANSPLAN P, 33(1-2), 2001, pp. 1015-1017
Donor bone marrow infusions are tolerogenic in human renal transplantation
Authors: Ciancio, G Garcia-Morales, R Mathew, J Carreno, M Burke, GW Ricordi, C Kenyon, N Esquenazi, V Cirocco, R Tzakis, A Miller, J
Citation: G. Ciancio et al., Donor bone marrow infusions are tolerogenic in human renal transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 1295-1296
Phenotypic marker and cytotoxic potential of hepatic lymphocytes isolated from rejected livers
Authors: Jin, Y Fuller, L Esquenazi, V Tzakis, AG Miller, J
Citation: Y. Jin et al., Phenotypic marker and cytotoxic potential of hepatic lymphocytes isolated from rejected livers, TRANSPLAN P, 33(1-2), 2001, pp. 1423-1425
Polyomavirus PCR monitoring in renal transplant recipients: Detection in blood is associated with higher creatinine values
Authors: Cirocco, R Markou, M Rosen, A Goldsmith, L Cianco, G Roth, D Kupin, W Burke, G Esquenazi, V Tzakis, A Miller, J
Citation: R. Cirocco et al., Polyomavirus PCR monitoring in renal transplant recipients: Detection in blood is associated with higher creatinine values, TRANSPLAN P, 33(1-2), 2001, pp. 1805-1807
Six-year clinical effect of donor bone marrow infusions in renal transplant patients
Authors: Ciancio, G Miller, J Garcia-Morales, RO Carreno, M Burke, GW Roth, D Kupin, W Tzakis, AG Ricordi, C Rosen, A Fuller, L Esquenazi, V
Citation: G. Ciancio et al., Six-year clinical effect of donor bone marrow infusions in renal transplant patients, TRANSPLANT, 71(7), 2001, pp. 827-835
Levels of mycophenolic acid and its glucuronide derivative in the plasma of liver, small bowel and kidney transplant patients receiving tacrolimus and cellcept combination therapy
Authors: Tsaroucha, AK Zucker, K Esquenazi, V de Faria, L Miller, J Tzakis, AG
Citation: Ak. Tsaroucha et al., Levels of mycophenolic acid and its glucuronide derivative in the plasma of liver, small bowel and kidney transplant patients receiving tacrolimus and cellcept combination therapy, TRANSPL IMM, 8(2), 2000, pp. 143-146
Bone marrow cells inhibit the generation of autologous EBV-specific CTL
Authors: Jin, YD Fuller, L Esquenazi, V Blomberg, BB Rosen, A Tzakis, AG Ricordi, C Miller, J
Citation: Yd. Jin et al., Bone marrow cells inhibit the generation of autologous EBV-specific CTL, HUMAN IMMUN, 61(6), 2000, pp. 538-547
Bone marrow cells promote TH2 polarization and inhibit virus-specific CTL generation
Authors: Jin, YD Fuller, L Wei, YT Blomberg, BB Miller, J Esquenazi, V
Citation: Yd. Jin et al., Bone marrow cells promote TH2 polarization and inhibit virus-specific CTL generation, HUMAN IMMUN, 61(12), 2000, pp. 1233-1241
Donor bone marrow-derived chimeric cells present in renal, transplant recipients infused with donor marrow. I. Potent regulators of recipient antidonor immune responses
Authors: Mathew, JM Garcia-Morales, R Fuller, L Rosen, A Ciancio, G Burke, GW Carreno, M Temple, D Tzakis, AG Ricordi, C Miller, C Esquenazi, V
Citation: Jm. Mathew et al., Donor bone marrow-derived chimeric cells present in renal, transplant recipients infused with donor marrow. I. Potent regulators of recipient antidonor immune responses, TRANSPLANT, 70(12), 2000, pp. 1675-1682
Involvement of multiple subpopulations of human bone marrow cells in the regulation of allogeneic cellular immune responses
Authors: Mathew, JM Fuller, L Carreno, M Garcia-Morales, R Burke, GW Ricordi, C Esquenazi, V Tzakis, AG Miller, J
Citation: Jm. Mathew et al., Involvement of multiple subpopulations of human bone marrow cells in the regulation of allogeneic cellular immune responses, TRANSPLANT, 70(12), 2000, pp. 1752-1760
Analysis of post-transplant immune status in recipients of liver/bone marrow allografts
Authors: Chatzipetrou, MA Mathew, JM Kenyon, NS Esquenazi, V Miller, J Ricordi, C Tzakis, AG
Citation: Ma. Chatzipetrou et al., Analysis of post-transplant immune status in recipients of liver/bone marrow allografts, HUMAN IMMUN, 60(12), 1999, pp. 1281-1288
Evidence that tacrolimus augments the bioavailability of mycophenolate mofetil through the inhibition of mycophenolic acid glucuronidation
Authors: Zucker, K Tsaroucha, A Olson, L Esquenazi, V Tzakis, A Miller, J
Citation: K. Zucker et al., Evidence that tacrolimus augments the bioavailability of mycophenolate mofetil through the inhibition of mycophenolic acid glucuronidation, THER DRUG M, 21(1), 1999, pp. 35-43
Donor bone marrow, chimerism, histocompatibility and renal allograft rejection
Authors: Ciancio, G Garcia-Morales, R Burke, GW Roth, D Esquenazi, V Tzakis, A Miller, J
Citation: G. Ciancio et al., Donor bone marrow, chimerism, histocompatibility and renal allograft rejection, TRANSPLAN P, 31(1-2), 1999, pp. 679-679
Kidney recipient CMV incidence in the gancyclovir era: Monitoring viral DNA by a CMV-PCR assay
Authors: Cirocco, RE Ciancio, G Esquenazi, V Burke, GW Miller, J
Citation: Re. Cirocco et al., Kidney recipient CMV incidence in the gancyclovir era: Monitoring viral DNA by a CMV-PCR assay, TRANSPLAN P, 31(1-2), 1999, pp. 1362-1363
Microangiopathy in kidney and simultaneous pancreas/kidney recipients treated with tacrolimus: Evidence of endothelin and cytokine involvement
Authors: Burke, GW Ciancio, G Cirocco, R Markou, M Olson, L Contreras, N Roth, D Esquenazi, V Tzakis, A Miller, J
Citation: Gw. Burke et al., Microangiopathy in kidney and simultaneous pancreas/kidney recipients treated with tacrolimus: Evidence of endothelin and cytokine involvement, TRANSPLANT, 68(9), 1999, pp. 1336-1342
The human bone marrow as an immunoregulatory organ
Authors: Miller, J Mathew, J Garcia-Morales, R Zucker, KE Carreno, M Jin, Y Fuller, L Burke, GW Ciancio, G Tzakis, AG Ricordi, C Olson, L Rosen, A Roth, D Esquenazi, V
Citation: J. Miller et al., The human bone marrow as an immunoregulatory organ, TRANSPLANT, 68(8), 1999, pp. 1079-1090
In vitro immunogenicity of cadaver donor bone marrow cells used for the induction of allograft acceptance in clinical transplantation
Authors: Mathew, JM Carreno, M Fuller, L Ricordi, C Kenyon, N Tzakis, AG Miller, J Esquenazi, V
Citation: Jm. Mathew et al., In vitro immunogenicity of cadaver donor bone marrow cells used for the induction of allograft acceptance in clinical transplantation, TRANSPLANT, 68(8), 1999, pp. 1172-1180
In situ enzymatic oligonucleotide amplification of hepatitis C virus RNA in liver biopsy specimens (reverse transcriptase in situ polymerase chain reaction) after orthotopic liver transplantation for hepatitis C-related liver disease
Authors: Fragulidis, GP Cirocco, RE Weppler, D Berho, M Gillian, G Markou, M Viciana, A Esquenazi, V Nery, JR Miller, J Reddy, KR Tzakis, AG
Citation: Gp. Fragulidis et al., In situ enzymatic oligonucleotide amplification of hepatitis C virus RNA in liver biopsy specimens (reverse transcriptase in situ polymerase chain reaction) after orthotopic liver transplantation for hepatitis C-related liver disease, TRANSPLANT, 66(11), 1998, pp. 1472-1476
Risultati: 1-21 |